Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
about
Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Evaluation and validation of t ...... receptor antagonist silodosin.
@en
Evaluation and validation of t ...... receptor antagonist silodosin.
@nl
type
label
Evaluation and validation of t ...... receptor antagonist silodosin.
@en
Evaluation and validation of t ...... receptor antagonist silodosin.
@nl
prefLabel
Evaluation and validation of t ...... receptor antagonist silodosin.
@en
Evaluation and validation of t ...... receptor antagonist silodosin.
@nl
P2093
P2860
P356
P1476
Evaluation and validation of t ...... receptor antagonist silodosin.
@en
P2093
Futoshi Sano
Hiroki Ito
Masahiro Yao
Takehiko Ogawa
P2860
P304
P356
10.1111/IJU.12167
P577
2013-05-12T00:00:00Z